Alexander Margi signed a binding contract to acquire Center Pharm (1988) Ltd. from Rekah Pharmaceutical Industry Ltd. (TASE:REKA) for ILS 4 million on May 29, 2017. Under the terms of the deal, ILS 0.5 million will be paid upon signing the agreement, ILS 2.4 million is payable upon completion and ILS 1.1 million payable in 6 equal quarterly installments, the first being a quarter following closing date. The buyer will acquire Center’s operations in four branches. Completion is subject to pre-conditions, such as antitrust commissioner’s approval and third parties approval. The deal is expected to close on July 15, 2017. Alexander Margi completed the acquisition of Center Pharm (1988) Ltd. from Rekah Pharmaceutical Industry Ltd. (TASE:REKA) on July 4, 2017.